SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing extreme volatility driven by a short squeeze, as traders react to a shrinking float and rising borrow fees while betting on the company's strategic pivot toward telecommunications infrastructure. The community remains deeply divided between aggressive bulls anticipating a move into triple digits and cautious observers warning of inevitable dilution and the risks of chasing a momentum-driven speculative play.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is at the center of investor focus following a quarterly report that featured record revenue, strong services growth, and a significant 100 billion dollar share buyback authorization. While some market participants are debating the impact of supply constraints and the upcoming leadership transition, the community remains actively divided between those highlighting the company's defensive strength and capital return efficiency versus skeptics questioning its long-term growth and innovation trajectory.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending following a significant earnings beat, with the community actively debating whether this performance marks a sustainable breakout or if the stock is prone to post-earnings volatility. Investors are particularly focused on the company's strong user growth and its potential to capitalize on AI data licensing as a core revenue driver.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is experiencing extreme volatility as investors react to a significant earnings blowout, where the company smashed revenue and EPS expectations alongside strong future guidance. While bulls celebrate the company's massive profitability and new share buyback program, the stock is seeing a "sell-the-news" reaction, leaving the community sharply divided between those calling for a rapid rebound and others warning that the shares remain overextended.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing heightened volatility ahead of earnings as investors weigh positive R2 production milestones and strategic partnerships against concerns over cash burn and potential share dilution. The community remains deeply divided, with bulls focusing on long-term production scaling and industrial partnerships, while bears point to persistent losses and capital structure risks.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox stock is facing downward pressure following a guidance cut attributed to the company's own age-verification rollout, which has slowed user acquisition and triggered negative sentiment among some investors. While some market participants are debating whether this represents a structural growth plateau or a temporary setback, others remain focused on the potential for long-term engagement growth and platform monetization.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as traders navigate extreme volatility driven by escalating geopolitical tensions in the Middle East and shifting sentiment around potential ceasefire negotiations. The community is actively debating the reliability of market-moving news regarding energy supply routes and the impact of these geopolitical developments on leveraged tech-heavy ETFs.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is seeing strong community interest driven by a series of earnings beats and the successful launch of its Athena AI platform, which continues to drive enterprise demand. Investors are actively debating the company's growth trajectory and AI integration, with many focused on the potential for institutional re-rating as the stock's fundamentals and scaling efforts gain traction.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending following a significant beat on both earnings and revenue, with the community actively debating the company's aggressive AI adoption through its 'Rovo' platform versus the long-term impact of its restructuring efforts. Investors are split between optimism over the company's potential to re-rate as a leading enterprise software provider and skepticism regarding future revenue guidance and the broader sustainability of SaaS business models in the current market environment.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending due to a major pivot toward autoimmune treatments, highlighted by a milestone payment from a Boehringer Ingelheim partnership and an upcoming R&D presentation on their lead candidate CUE-401. Community members are actively debating the company's long-term potential under new leadership against concerns regarding historical performance and potential reverse split volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cerus (CERS) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Cerus Q1 Earnings Call Highlights

Cerus (NASDAQ:CERS) reported first-quarter 2026 product revenue of $53.7 million, up 24% from the prior-year period, as management pointed to continued strength in its global INTERCEPT platelet franchise and accelerating demand for its INTERCEPT Fibrinogen Complex (IFC) business in the United States...

Cerus Q1 2026 Earnings Call Transcript

Cerus Corporation Announces First Quarter 2026 Financial Results

Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2026, and provided a business update. We delivered a strong start to 2026, with first quarter...

Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with tablissement Franais du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood...

Cerus (CERS) to Release Earnings on Thursday

Cerus (NASDAQ:CERS) will be releasing its Q1 2026 earnings after the market closes on Thursday, April 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-30-cerus-co-stock...

Sumitomo Mitsui Trust Group Inc. Sells 975,218 Shares of Cerus Corporation $CERS

Sumitomo Mitsui Trust Group Inc. cut its holdings in shares of Cerus Corporation (NASDAQ:CERS - Free Report) by 17.2% during the 4th quarter, according to its most recent Form 13F filing with the...

Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host...

Cerus (NASDAQ:CERS) Shares Cross Above 200-Day Moving Average   - Time to Sell?

Cerus (NASDAQ:CERS) Stock Passes Above 200 Day Moving Average - What's Next...

Cerus Corporation (NASDAQ:CERS) Short Interest Update

Cerus Corporation (NASDAQ:CERS - Get Free Report) saw a significant growth in short interest in the month of March. As of March 13th, there was short interest totaling 10,511,205 shares, a growth of...

$CERS Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.01 up 75.00% YoY
• Reported revenue of $59.89M up 22.60% YoY
• Cerus now expects full-year 2026 product revenue between $227 million and $231 million, a 10% to 12% growth from 2025, including $22 million to $24 million in INTERCEPT Fibrinogen Complex revenue guidance.

Stocktwits

Cerus Corp.

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.01 up 75.00% YoY
• Reported revenue of $59.89M up 22.60% YoY
• Cerus now expects full-year 2026 product revenue between $227 million and $231 million, a 10% to 12% growth from 2025, including $22 million to $24 million in INTERCEPT Fibrinogen Complex revenue guidance.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

CERS
Cerus Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CERS News

CERSCerus Corp.